4.6 Article

In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2008.04.187

Keywords

SLUG; VDR; E2-box; transcriptional repression; CtBP1; HDAC1

Funding

  1. NCI NIH HHS [U54 CA091408-010003, U54CA91408, U54 CA091408] Funding Source: Medline
  2. NCRR NIH HHS [G12 RR003032, U54RR019192-04, U54 RR019192, G12RR03032-19] Funding Source: Medline
  3. NHLBI NIH HHS [T32 HL007737, T32 HL007737-16] Funding Source: Medline
  4. NINDS NIH HHS [U54 NS041071, U54NS041071-06] Funding Source: Medline

Ask authors/readers for more resources

The regulation of vitamin D receptor (VDR), a key mediator in the vitamin D pathway, in breast cancer etiology has long been of interest. We have shown here that the transcriptional repressor protein SLUG inhibits the expression of VDR in human breast cancer cells. To explore the possibility that SLUG regulates the VDR gene promoter, we cloned a 628 bp fragment (-613 to +15) of the human VDR gene promoter. This region contains three E2-box sequences (CAGGTG/CACCTG), the classical binding site of SLUG. SLUG specifically inhibited VDR gene promoter activity. Chromatin-immunoprecipitation (ChIP) assays revealed that SLUG is recruited on the native VDR gene promoter along with the co-repressor protein CtBP1 and the effector protein HDAC1. These data suggests that SLUG binds to the E2-box sequences of the VDR gene promoter and recruits CtBP1 and HDAC1, which results in the inhibition of VDR gene expression by chromatin remodeling. (C) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available